A five-day course of ivermectin may reduce the duration of COVID-19 illness.

Ahmed, Sabeena; Khan, Wasif Ali

Ahmed, Sabeena; Khan, Wasif Ali.

Ahmed S; Senior Research Investigator, Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh. Electronic address: sabeena@icddrb.org.
Khan WA; Scientist, Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh. Electronic address: wakhan@icddrb.org.

Int J Infect Dis ; 110: 93-94, 2021 09.

Article in English | MEDLINE | ID: covidwho-1330868

Subject(s)

COVID-19; Ivermectin; Antiviral Agents/therapeutic use; Humans; SARS-CoV-2

Keywords

COVID-19; antiviral effect; ivermectin

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ivermectin / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google